Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients

Chinese Medical Journal

Volumn 126, Issue 1, 2013, Pages 11-15

  Zhou, Qing Tao ^a   Mei, Jing Jing ^a   He, Bei ^a   Huang, Shao Guang ^b   Shi, Yi ^c   Wen, Fu Qiang ^d   Zhao, Ming Wu ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Dyspnea; Quality of life; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; CHINESE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DYSPNEA; EDUCATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; SCORING SYSTEM; SOCIAL STATUS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84874347841     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121090     Document Type: Article

References (25)

1. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD, 2011. (Accessed Jan 5, 2012 at http://www.goldcopd.org)
2. Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest 2011; 139: 920-929.
3. Chen YH, Yao WZ, Cai BQ, Wang H, Deng XM, Gao HL, et al. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J 2008; 121: 587-591.
4. Vaz Fragoso CA, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 446-451.
5. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
6. Cerveri I, Corsico AG, Accordini S, Niniano R, Ansaldo E, Antó JM, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.
7. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC< 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105: 907-915.
8. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes of COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008; 31: 416-469.
9. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85 Suppl B: 25-31.
10. Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved COPD-specific version of the St George's Respiratory Questionnaire. Chest 2007; 132: 456-463.
11. Liu R, Du YP, He B. Relationship between SGRQ score and pulmonary function and its influencing factors in patients with chronic obstructive pulmonary disease. Natl Med J China (Chin) 2011; 91: 1533-1537.
12. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34: 648-654.
13. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT™) scores. BMC Pulm Med 2011; 11: 42.
14. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38: 29-35.
15. Wiklund I, Berry P, Lu KX, Fang J, Fu C. The Chinese translation of COPD Assessment Test™ (CAT) provides a valid and reliable measurement of COPD health status in Chinese COPD patients. Am J Respir Crit Care Med 2010; 181: A3575.
16. Chai JJ, Liu T, Cai BQ. Evaluation of clinical significance of chronic obstructive pulmonary disease assessment test. Chin J Tuberc Respir Dis (Chin) 2011; 34: 256-258.
17. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, et al. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest 2012; 142: 134-140.
18. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011; 66: 425-429.
19. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978; 118 (6 Pt 2): 1-120.
20. Camargo LA, Pereira CA. Dyspnea in COPD: beyond the modified Medical Research Council scale. J Bras Pneumol 2010; 36: 571-578.
21. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185-1189.
22. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
23. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD, 2009. (Accessed Jan. 10, 2010 at http://www.goldcopd.org)
24. Kelly JL, Bamsey O, Smith C, Lord VM, Shrikrishna D, Jones PW, et al. Health status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatients. Respiration 2012; 84: 193-199.
25. Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-760.